HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,640: | Line 1,640: | ||
|In Situ Mantle Cell Neoplasia | |In Situ Mantle Cell Neoplasia | ||
|Rina Kansal, MD; Versiti Blood Center of Wisconsin | |Rina Kansal, MD; Versiti Blood Center of Wisconsin | ||
| | |Complete | ||
| | |7/26/2022 | ||
| | | | ||
|- | |- | ||
| Line 1,660: | Line 1,660: | ||
|Target completion date 8/15/20 | |Target completion date 8/15/20 | ||
|- | |- | ||
|Leukaemic non-nodal mantle cell lymphoma | |[[HAEM5:Leukaemic non-nodal mantle cell lymphoma|Leukaemic non-nodal mantle cell lymphoma]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,676: | Line 1,676: | ||
|NEW (No Prior) | |NEW (No Prior) | ||
|- | |- | ||
|Transformations of indolent B-cell lymphomas | |[[HAEM5:Transformations of indolent B-cell lymphomas|Transformations of indolent B-cell lymphomas]] | ||
|Disease | |Disease | ||
| | | | ||
| Line 1,685: | Line 1,685: | ||
|SG | |SG | ||
| | | | ||
| | |Include content on chronic myelomonocytic leukemia in transformation and refractory anaemia with excess blasts in transformation | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Diffuse large B-cell lymphoma, NOS||Disease|| || || || || ||GC|| || | |Diffuse large B-cell lymphoma, NOS||Disease|| || || || || ||GC|| || | ||